The effects of hepatocyte steatosis and adipocytokines on HCV replication
The effects of hepatocyte steatosis and adipocytokines on HCV replication
批准号:
20590475
负责人:
YAMASHIRO Tsuyoshi
金额:
$2.66万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2010
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Hepatitis C virus(HCV) is a health-care problem causing a spectrum of liver disease ranging from chronic hepatitis to liver cirrhosis and hepatocellular carcinoma. Anti-HCV treatments are based on a major antiviral cytokine, interferon(IFN). Obesity is reported to be an independent negative predictor of response to hepatitis C treatment. In the present study, we examined the influence of hepatocyte steatosis induced by free fatty acid on HCV replication and the action of adipocytokine(adiponectin, resistin, PAI-1) alone, or in combination with IFN, on HCV replication using the replicon system. Our results showed that hepatocyte steatosis and adipocytokines had no effect on HCV replication.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
すべての内科医に役立つ肝疾患なるほどQ&A
对所有内科医生有用的肝病问答
DOI:
--
发表时间:
2011
期刊:
影响因子:
--
作者:
[J-i Sakuragi*, et al., 泉並木]
通讯作者:
泉並木
Legionella pneumophila contamination in a steam towel wanner in a hospital setting
医院环境中蒸汽毛巾加热机中的嗜肺军团菌污染
DOI:
--
发表时间:
2012
期刊:
J Hosp Infect
影响因子:
6.9
作者:
[H.Maegawa, T.Miyamoto, J.-i.Sakuragi, T.Shioda, E.E.Nakayama., Yokota Shin-ichi, Jun-ichi Sakuragi, Kasai D, Yokota Shin-ichi, Jun-ichi Sakuragi, Kato N, Higa F]
通讯作者:
Higa F
Role of neuraminidase inhibitor chemoprophylaxis in controlling nosocomial influenza: an observational study.
神经氨酸酶抑制剂化学预防中的作用在控制医院流感:一项观察性研究。
DOI:
10.1111/j.1750-2659.2011.00311.x
发表时间:
2012-07
期刊:
Influenza and other respiratory viruses
影响因子:
4.4
作者:
[Higa F, Tateyama M, Tomishima M, Mukatake S, Yamashiro T, Owan T, Haranaga S, Fujita J]
通讯作者:
Fujita J
Inhibition of intracellular hepatitis C virus replication by nelfinavir and synergistic effect with interferon-alpha
奈非那韦抑制细胞内丙型肝炎病毒复制及其与干扰素-α的协同作用
DOI:
--
发表时间:
2009
期刊:
Journal of Viral Hepatitis
影响因子:
2.5
作者:
[Toma S, Yamashiro T, Arakaki S, Shiroma J, Maeshiro T, Hibiya K, Sakamoto N, Tateyama M, Kinjyo F, Fujita J]
通讯作者:
Fujita J
海外基金